A. LimsuwanP. PienvichitP. KhowsathitMahidol University2018-06-212018-06-212005-12-01Pediatric Cardiology. Vol.26, No.6 (2005), 787-791017206432-s2.0-31144458147https://repository.li.mahidol.ac.th/handle/20.500.14594/16678We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed. © Springer Science+Business Media, Inc. 2005.Mahidol UniversityMedicineArticleSCOPUS10.1007/s00246-005-0925-4